HSPA9 and Alzheimer disease: Seth, in his 2022 review, details that an excess of mortalin aids in the irregular proliferation observed in cancer cells, while inhibiting mortalin promotes oxidative stress, enhances mitochondrial functions, and reduces lifespan in pathologies such as AD, PD, and HIV.